Skip to main content
Erschienen in: World Journal of Urology 2/2019

04.01.2019 | Invited Review

Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?

verfasst von: Giancarlo Marra, Guillaume Ploussard, Jurgen Futterer, Massimo Valerio, the EAU-YAU Prostate Cancer Working Party

Erschienen in: World Journal of Urology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To review the evidence addressing current controversies around prostate biopsy. Specific questions explored were (1) mpMRI targeted (TgBx) alone versus combined with systematic (SBx) biopsy; (2) cognitive versus software-based targeted biopsy; (3) transrectal or transperineal route (TP).

Methods

We performed a literature search of peer-reviewed English language articles using PubMed and the words “prostate” AND “biopsy”. Web search was implemented by manual search.

Results

Prostate mpMRI is revolutionizing prostate cancer (PCa) diagnosis, and TgBx improves the detection of clinically significant (cs) PCa compared to SBx alone. The utility of combining SBx–TgBx is variable, but in non-expert centres the two should be combined to overcome learning curve-limitations. Whether SBx should be maintained in expert centres depends on what rate of missed cancer the urological community and patients are prone to accept; this has implications for insignificant cancer diagnosis as well. TgBx may be more precise using a software-based-approach despite cognitive TgBx proved non-inferior in some studies, and may be used for large accessible lesions. TP-biopsies are feasible in an in-office setting. Avoidance of the rectum and accessibility of virtually all prostate areas are attractive features. However, this has to be balanced with local setting and resources implications. Ongoing trials will shed light on unsolved issues.

Conclusion

The prostate biopsy strategy should be tailored to local expertise, needs and resources availability. Targeted biopsy enhance the ratio between cs and insignificant cancer diagnosis, although some csPCa might be missed. Software-based TgBx are likely to be more precise, especially for new users, although the additional cost might be not justified in all cases. TPBx have ideal attributes for performing TgBx and avoiding infection, although this has resources implications.
Literatur
1.
Zurück zum Zitat Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74 (discussion 4–5) CrossRefPubMed Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74 (discussion 4–5) CrossRefPubMed
2.
Zurück zum Zitat Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C (2006) Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 175:485–488CrossRefPubMed Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C (2006) Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 175:485–488CrossRefPubMed
3.
Zurück zum Zitat Vyas L, Acher P, Kinsella J et al (2013) Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int 114:32–37CrossRef Vyas L, Acher P, Kinsella J et al (2013) Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int 114:32–37CrossRef
4.
Zurück zum Zitat Marra G, Eldred-Evans D, Challacombe B et al (2017) Pathological concordance between prostate biopsies and radical prostatectomy using transperineal sector mapping biopsies: validation and comparison with transrectal biopsies. Urol Int 99:168–176CrossRefPubMed Marra G, Eldred-Evans D, Challacombe B et al (2017) Pathological concordance between prostate biopsies and radical prostatectomy using transperineal sector mapping biopsies: validation and comparison with transrectal biopsies. Urol Int 99:168–176CrossRefPubMed
6.
Zurück zum Zitat Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629CrossRefPubMed Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629CrossRefPubMed
7.
Zurück zum Zitat Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J (2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175:1605–1612CrossRefPubMed Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J (2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175:1605–1612CrossRefPubMed
8.
Zurück zum Zitat Schouten MG, van der Leest M, Pokorny M et al (2017) Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naive men? Eur Urol 71:896–903CrossRefPubMed Schouten MG, van der Leest M, Pokorny M et al (2017) Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naive men? Eur Urol 71:896–903CrossRefPubMed
9.
Zurück zum Zitat Marra G, Gontero P, Valerio M (2016) Changing the prostate cancer management pathway: why focal therapy is a step forward. Arch Esp Urol 69:271–280PubMed Marra G, Gontero P, Valerio M (2016) Changing the prostate cancer management pathway: why focal therapy is a step forward. Arch Esp Urol 69:271–280PubMed
10.
Zurück zum Zitat Futterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68:1045–1053CrossRefPubMed Futterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68:1045–1053CrossRefPubMed
11.
Zurück zum Zitat Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 15(344):495–500CrossRef Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 15(344):495–500CrossRef
12.
Zurück zum Zitat Burman KD, Wartofsky L, CLINICAL PRACTICE (2015) Thyroid nodules. N Engl J Med 373:2347–2356CrossRefPubMed Burman KD, Wartofsky L, CLINICAL PRACTICE (2015) Thyroid nodules. N Engl J Med 373:2347–2356CrossRefPubMed
13.
Zurück zum Zitat Marconi L, Dabestani S, Lam TB et al (2016) Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 69:660–673CrossRefPubMed Marconi L, Dabestani S, Lam TB et al (2016) Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 69:660–673CrossRefPubMed
14.
Zurück zum Zitat Larscheid RC, Thorpe PE, Scott WJ (1998) Percutaneous transthoracic needle aspiration biopsy. Chest 114:704–709CrossRefPubMed Larscheid RC, Thorpe PE, Scott WJ (1998) Percutaneous transthoracic needle aspiration biopsy. Chest 114:704–709CrossRefPubMed
15.
Zurück zum Zitat Borofsky S, George AK, Gaur S et al (2018) What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology 286:186–195CrossRefPubMed Borofsky S, George AK, Gaur S et al (2018) What are we missing? False-negative cancers at multiparametric MR imaging of the prostate. Radiology 286:186–195CrossRefPubMed
16.
Zurück zum Zitat Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP (2017) Impact of Gleason subtype on prostate cancer detection using multiparametric magnetic resonance imaging: correlation with final histopathology. J Urol 198(2):316–321CrossRefPubMed Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP (2017) Impact of Gleason subtype on prostate cancer detection using multiparametric magnetic resonance imaging: correlation with final histopathology. J Urol 198(2):316–321CrossRefPubMed
17.
Zurück zum Zitat Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 27(313):390–397CrossRef Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 27(313):390–397CrossRef
18.
Zurück zum Zitat Baco E, Rud E, Eri LM et al (2016) A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 69:149–156CrossRefPubMed Baco E, Rud E, Eri LM et al (2016) A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur Urol 69:149–156CrossRefPubMed
19.
Zurück zum Zitat Rosenkrantz AB, Verma S, Choyke P et al (2016) Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol 196:1613–1618CrossRefPubMedPubMedCentral Rosenkrantz AB, Verma S, Choyke P et al (2016) Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol 196:1613–1618CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Scheltema MJ, Tay KJ, Postema AW et al (2017) Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. World J Urol 35:695–701CrossRefPubMed Scheltema MJ, Tay KJ, Postema AW et al (2017) Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. World J Urol 35:695–701CrossRefPubMed
21.
Zurück zum Zitat Wegelin O, van Melick HHE, Hooft L et al (2017) Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 71:517–531CrossRefPubMed Wegelin O, van Melick HHE, Hooft L et al (2017) Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique? Eur Urol 71:517–531CrossRefPubMed
22.
Zurück zum Zitat Davis P, Paul E, Grummet J (2015) Current practice of prostate biopsy in Australia and New Zealand: a survey. Urol Ann 7:315–319PubMedPubMedCentral Davis P, Paul E, Grummet J (2015) Current practice of prostate biopsy in Australia and New Zealand: a survey. Urol Ann 7:315–319PubMedPubMedCentral
23.
Zurück zum Zitat Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefPubMed Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815–822CrossRefPubMed
24.
Zurück zum Zitat Valerio M, Donaldson I, Emberton M et al (2014) Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68(1):8–19CrossRefPubMed Valerio M, Donaldson I, Emberton M et al (2014) Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68(1):8–19CrossRefPubMed
25.
Zurück zum Zitat Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG (2014) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438CrossRefPubMed Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG (2014) Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68:438CrossRefPubMed
26.
Zurück zum Zitat Porpiglia F, Manfredi M, Mele F et al (2017) Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naive patients with suspected prostate cancer. Eur Urol 72:282–288CrossRefPubMed Porpiglia F, Manfredi M, Mele F et al (2017) Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naive patients with suspected prostate cancer. Eur Urol 72:282–288CrossRefPubMed
27.
Zurück zum Zitat Tonttila PP, Lantto J, Paakko E et al (2016) Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69:419–425CrossRefPubMed Tonttila PP, Lantto J, Paakko E et al (2016) Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol 69:419–425CrossRefPubMed
28.
Zurück zum Zitat Panebianco V, Barchetti F, Sciarra A et al (2015) Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol 33:17CrossRefPubMed Panebianco V, Barchetti F, Sciarra A et al (2015) Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol 33:17CrossRefPubMed
29.
Zurück zum Zitat Park BK, Park JW, Park SY et al (2011) Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol 197:W876–W881CrossRefPubMed Park BK, Park JW, Park SY et al (2011) Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol 197:W876–W881CrossRefPubMed
30.
Zurück zum Zitat Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767–1777CrossRefPubMedPubMedCentral Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767–1777CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Haffner J, Lemaitre L, Puech P et al (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108:E171–E178CrossRefPubMed Haffner J, Lemaitre L, Puech P et al (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108:E171–E178CrossRefPubMed
33.
Zurück zum Zitat Valerio M, Donaldson I, Emberton M et al (2015) Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68:8–19CrossRefPubMed Valerio M, Donaldson I, Emberton M et al (2015) Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68:8–19CrossRefPubMed
34.
Zurück zum Zitat Salami SS, Ben-Levi E, Yaskiv O et al (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115:562–570CrossRefPubMed Salami SS, Ben-Levi E, Yaskiv O et al (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115:562–570CrossRefPubMed
35.
Zurück zum Zitat Albisinni S, Aoun F, Noel A et al (2018) Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies? Progres en urologie: journal de l’Association francaise d’urologie et de la Societe francaise d’urologie 28:18–24CrossRef Albisinni S, Aoun F, Noel A et al (2018) Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies? Progres en urologie: journal de l’Association francaise d’urologie et de la Societe francaise d’urologie 28:18–24CrossRef
36.
Zurück zum Zitat Radtke JP, Kuru TH, Boxler S et al (2015) Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193:87–94CrossRefPubMed Radtke JP, Kuru TH, Boxler S et al (2015) Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. J Urol 193:87–94CrossRefPubMed
37.
Zurück zum Zitat Cash H, Gunzel K, Maxeiner A et al (2016) Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. BJU Int. 118:35–43CrossRefPubMed Cash H, Gunzel K, Maxeiner A et al (2016) Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. BJU Int. 118:35–43CrossRefPubMed
38.
Zurück zum Zitat Moldovan PC, Van den Broeck T, Sylvester R et al (2017) What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur Urol 72:250–266CrossRefPubMed Moldovan PC, Van den Broeck T, Sylvester R et al (2017) What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur Urol 72:250–266CrossRefPubMed
39.
Zurück zum Zitat Oderda M, Marra G, Albisinni S et al (2018) Accuracy of elastic fusion biopsy in daily practice: results of a multicenter study of 2115 patients. Int J Urol Off J Jpn Urol Assoc 25:990 Oderda M, Marra G, Albisinni S et al (2018) Accuracy of elastic fusion biopsy in daily practice: results of a multicenter study of 2115 patients. Int J Urol Off J Jpn Urol Assoc 25:990
40.
Zurück zum Zitat Mischinger J, Kaufmann S, Russo GI et al (2017) Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy. BJU Int 125:791 Mischinger J, Kaufmann S, Russo GI et al (2017) Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy. BJU Int 125:791
41.
Zurück zum Zitat Borkowetz A, Hadaschik B, Platzek I et al (2018) Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naive patients. BJU Int 121:53–60CrossRefPubMed Borkowetz A, Hadaschik B, Platzek I et al (2018) Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naive patients. BJU Int 121:53–60CrossRefPubMed
43.
Zurück zum Zitat Marra G, Ploussard G, Ost P et al (2018) Focal therapy in localised prostate cancer: real-world urological perspective explored in a cross-sectional European survey. Urol Oncol 36:529PubMed Marra G, Ploussard G, Ost P et al (2018) Focal therapy in localised prostate cancer: real-world urological perspective explored in a cross-sectional European survey. Urol Oncol 36:529PubMed
44.
Zurück zum Zitat van der Poel HG, van den Bergh RCN, Briers E et al (2018) Focal therapy in primary localised prostate cancer: the European Association of Urology Position in 2018. Eur Urol 74(1):84–91CrossRefPubMed van der Poel HG, van den Bergh RCN, Briers E et al (2018) Focal therapy in primary localised prostate cancer: the European Association of Urology Position in 2018. Eur Urol 74(1):84–91CrossRefPubMed
45.
Zurück zum Zitat Gaziev G, Wadhwa K, Barrett T et al (2016) Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. BJU Int 117:80–86CrossRefPubMed Gaziev G, Wadhwa K, Barrett T et al (2016) Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. BJU Int 117:80–86CrossRefPubMed
46.
Zurück zum Zitat Dimitroulis P, Rabenalt R, Nini A et al (2018) Multiparametric magnetic resonance imaging/ultrasound fusion prostate biopsy—are 2 biopsy cores per magnetic resonance imaging lesion required? J Urol 200:1030–1034CrossRefPubMed Dimitroulis P, Rabenalt R, Nini A et al (2018) Multiparametric magnetic resonance imaging/ultrasound fusion prostate biopsy—are 2 biopsy cores per magnetic resonance imaging lesion required? J Urol 200:1030–1034CrossRefPubMed
47.
Zurück zum Zitat Schimmoller L, Quentin M, Blondin D et al (2016) Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required? Eur Radiol 26:3858–3864CrossRefPubMed Schimmoller L, Quentin M, Blondin D et al (2016) Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required? Eur Radiol 26:3858–3864CrossRefPubMed
48.
Zurück zum Zitat Porpiglia F, De Luca S, Passera R et al (2017) Multiparametric magnetic resonance/ultrasound fusion prostate biopsy: number and spatial distribution of cores for better index tumor detection and characterization. J Urol 198:58–64CrossRefPubMed Porpiglia F, De Luca S, Passera R et al (2017) Multiparametric magnetic resonance/ultrasound fusion prostate biopsy: number and spatial distribution of cores for better index tumor detection and characterization. J Urol 198:58–64CrossRefPubMed
49.
Zurück zum Zitat Robertson NL, Hu Y, Ahmed HU, Freeman A, Barratt D, Emberton M (2014) Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study. Eur Urol 65:628–634CrossRefPubMedPubMedCentral Robertson NL, Hu Y, Ahmed HU, Freeman A, Barratt D, Emberton M (2014) Prostate cancer risk inflation as a consequence of image-targeted biopsy of the prostate: a computer simulation study. Eur Urol 65:628–634CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Neill MG, Toi A, Lockwood GA, Evans A, Tammsalu L, Fleshner NE (2008) Systematic lateral prostate biopsy—are the benefits worth the costs? J Urol 179:1321–1326CrossRefPubMed Neill MG, Toi A, Lockwood GA, Evans A, Tammsalu L, Fleshner NE (2008) Systematic lateral prostate biopsy—are the benefits worth the costs? J Urol 179:1321–1326CrossRefPubMed
51.
Zurück zum Zitat Delongchamps NB, Peyromaure M, Schull A et al (2013) Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 189:493–499CrossRefPubMed Delongchamps NB, Peyromaure M, Schull A et al (2013) Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 189:493–499CrossRefPubMed
52.
Zurück zum Zitat Oderda M, Faletti R, Battisti G et al (2016) Prostate cancer detection rate with koelis fusion biopsies versus cognitive biopsies: a comparative study. Urol Int 97:230–237CrossRefPubMed Oderda M, Faletti R, Battisti G et al (2016) Prostate cancer detection rate with koelis fusion biopsies versus cognitive biopsies: a comparative study. Urol Int 97:230–237CrossRefPubMed
53.
Zurück zum Zitat Puech P, Rouviere O, Renard-Penna R et al (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy—prospective multicenter study. Radiology 268:461–469CrossRefPubMed Puech P, Rouviere O, Renard-Penna R et al (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy—prospective multicenter study. Radiology 268:461–469CrossRefPubMed
54.
Zurück zum Zitat Wysock JS, Rosenkrantz AB, Huang WC et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66:343–351CrossRefPubMed Wysock JS, Rosenkrantz AB, Huang WC et al (2014) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 66:343–351CrossRefPubMed
55.
Zurück zum Zitat Valerio M, McCartan N, Freeman A, Punwani S, Emberton M, Ahmed HU (2015) Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. Urol Oncol 33:424CrossRefPubMed Valerio M, McCartan N, Freeman A, Punwani S, Emberton M, Ahmed HU (2015) Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer. Urol Oncol 33:424CrossRefPubMed
56.
Zurück zum Zitat De Silva T, Fenster A, Cool DW et al (2013) 2D-3D rigid registration to compensate for prostate motion during 3D TRUS-guided biopsy. Med Phys 40:022904CrossRefPubMed De Silva T, Fenster A, Cool DW et al (2013) 2D-3D rigid registration to compensate for prostate motion during 3D TRUS-guided biopsy. Med Phys 40:022904CrossRefPubMed
57.
Zurück zum Zitat Hu Y, Ahmed HU, Taylor Z et al (2012) MR to ultrasound registration for image-guided prostate interventions. Med Image Anal 16:687–703CrossRefPubMed Hu Y, Ahmed HU, Taylor Z et al (2012) MR to ultrasound registration for image-guided prostate interventions. Med Image Anal 16:687–703CrossRefPubMed
58.
Zurück zum Zitat Baumann M, Mozer P, Daanen V, Troccaz J (2012) Prostate biopsy tracking with deformation estimation. Med Image Anal 16:562–576CrossRefPubMed Baumann M, Mozer P, Daanen V, Troccaz J (2012) Prostate biopsy tracking with deformation estimation. Med Image Anal 16:562–576CrossRefPubMed
59.
Zurück zum Zitat Moldovan P, Udrescu C, Ravier E et al (2016) Accuracy of elastic fusion of prostate magnetic resonance and transrectal ultrasound images under routine conditions: a prospective multi-operator study. PLoS One 11:e0169120CrossRefPubMedPubMedCentral Moldovan P, Udrescu C, Ravier E et al (2016) Accuracy of elastic fusion of prostate magnetic resonance and transrectal ultrasound images under routine conditions: a prospective multi-operator study. PLoS One 11:e0169120CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Meng X, Rosenkrantz AB, Huang R et al (2018) The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years. J Urol 200:1022–1029CrossRefPubMed Meng X, Rosenkrantz AB, Huang R et al (2018) The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years. J Urol 200:1022–1029CrossRefPubMed
61.
Zurück zum Zitat Mager R, Brandt MP, Borgmann H, Gust KM, Haferkamp A, Kurosch M (2017) From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy. Int Urol Nephrol 49:1537–1544CrossRefPubMed Mager R, Brandt MP, Borgmann H, Gust KM, Haferkamp A, Kurosch M (2017) From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy. Int Urol Nephrol 49:1537–1544CrossRefPubMed
62.
Zurück zum Zitat Friedl A, Schneeweiss J, Sevcenco S et al (2018) In-bore 3.0-T magnetic resonance imaging-guided transrectal targeted prostate biopsy in a repeat biopsy population: diagnostic performance, complications, and learning curve. Urology 114:139–146CrossRefPubMed Friedl A, Schneeweiss J, Sevcenco S et al (2018) In-bore 3.0-T magnetic resonance imaging-guided transrectal targeted prostate biopsy in a repeat biopsy population: diagnostic performance, complications, and learning curve. Urology 114:139–146CrossRefPubMed
63.
Zurück zum Zitat Stabile A, Dell’Oglio P, Gandaglia G et al (2018) Not all multiparametric magnetic resonance imaging—targeted biopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer. Eur Urol Oncol 1:120–128CrossRefPubMed Stabile A, Dell’Oglio P, Gandaglia G et al (2018) Not all multiparametric magnetic resonance imaging—targeted biopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer. Eur Urol Oncol 1:120–128CrossRefPubMed
64.
Zurück zum Zitat Barrett T, Patterson AJ, Koo BC et al (2016) Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors. World J Urol 34:501–508CrossRefPubMed Barrett T, Patterson AJ, Koo BC et al (2016) Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors. World J Urol 34:501–508CrossRefPubMed
65.
Zurück zum Zitat Wegelin O, van Melick HHE (2015) Fusion target biopsy of the prostate using real-time ultrasound and mr images A multicenter RCT on target biopsy techniques in the diagnosis of prostate cancer. J Clin Trials 5:248CrossRef Wegelin O, van Melick HHE (2015) Fusion target biopsy of the prostate using real-time ultrasound and mr images A multicenter RCT on target biopsy techniques in the diagnosis of prostate cancer. J Clin Trials 5:248CrossRef
66.
Zurück zum Zitat Emiliozzi P, Corsetti A, Tassi B, Federico G, Martini M, Pansadoro V (2003) Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 61:961–966CrossRefPubMed Emiliozzi P, Corsetti A, Tassi B, Federico G, Martini M, Pansadoro V (2003) Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 61:961–966CrossRefPubMed
67.
Zurück zum Zitat Alanis AJ (2005) Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36:697–705CrossRefPubMed Alanis AJ (2005) Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36:697–705CrossRefPubMed
68.
Zurück zum Zitat Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schroder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110–1114CrossRefPubMed Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schroder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61:1110–1114CrossRefPubMed
69.
Zurück zum Zitat Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876–892CrossRefPubMed Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876–892CrossRefPubMed
70.
Zurück zum Zitat Liss MA, Taylor SA, Batura D et al (2014) Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol 192:1673–1678CrossRefPubMed Liss MA, Taylor SA, Batura D et al (2014) Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol 192:1673–1678CrossRefPubMed
71.
Zurück zum Zitat Chung HS, Hwang EC, Yu HS et al (2017) Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: a prospective multicenter study. Int J Urol Off J Jpn Urol Assoc 25(3):278–283 Chung HS, Hwang EC, Yu HS et al (2017) Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: a prospective multicenter study. Int J Urol Off J Jpn Urol Assoc 25(3):278–283
72.
Zurück zum Zitat Liss MA, Ehdaie B, Loeb S et al (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198:329–334CrossRefPubMed Liss MA, Ehdaie B, Loeb S et al (2017) An update of the American urological association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198:329–334CrossRefPubMed
74.
Zurück zum Zitat Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J (2012) Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62:453–459CrossRefPubMed Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J (2012) Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62:453–459CrossRefPubMed
75.
Zurück zum Zitat Seitz M, Stief C, Waidelich R, Bader M, Tilki D (2017) Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem. World J Urol 35:1681–1688CrossRefPubMed Seitz M, Stief C, Waidelich R, Bader M, Tilki D (2017) Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem. World J Urol 35:1681–1688CrossRefPubMed
76.
Zurück zum Zitat Bloomfield MG, Page MJ, McLachlan AG, Studd RC, Blackmore TK (2017) Routine ertapenem prophylaxis for transrectal ultrasound guided prostate biopsy does not select for carbapenem resistant organisms: a prospective cohort study. J Urol 198:362–368CrossRefPubMed Bloomfield MG, Page MJ, McLachlan AG, Studd RC, Blackmore TK (2017) Routine ertapenem prophylaxis for transrectal ultrasound guided prostate biopsy does not select for carbapenem resistant organisms: a prospective cohort study. J Urol 198:362–368CrossRefPubMed
77.
Zurück zum Zitat Pepdjonovic L, Tan GH, Huang S et al (2017) Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol 35:1199–1203CrossRefPubMed Pepdjonovic L, Tan GH, Huang S et al (2017) Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis. World J Urol 35:1199–1203CrossRefPubMed
78.
Zurück zum Zitat Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81:1142–1146CrossRefPubMed Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81:1142–1146CrossRefPubMed
79.
Zurück zum Zitat Grummet J, Pepdjonovic L, Moon D (2017) Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 71:353–365CrossRef Grummet J, Pepdjonovic L, Moon D (2017) Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 71:353–365CrossRef
80.
Zurück zum Zitat Grummet JP, Weerakoon M, Huang S et al (2014) Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114:384–388PubMed Grummet JP, Weerakoon M, Huang S et al (2014) Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114:384–388PubMed
81.
Zurück zum Zitat Meyer AR, Joice GA, Schwen ZR, Partin AW, Allaf ME, Gorin MA (2018) Initial experience performing in-office ultrasound-guided transperineal prostate biopsy under local anesthesia using the precision point transperineal access system. Urology 115:8–13CrossRefPubMed Meyer AR, Joice GA, Schwen ZR, Partin AW, Allaf ME, Gorin MA (2018) Initial experience performing in-office ultrasound-guided transperineal prostate biopsy under local anesthesia using the precision point transperineal access system. Urology 115:8–13CrossRefPubMed
82.
Zurück zum Zitat Kuru TH, Wadhwa K, Chang RT et al (2013) Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. BJU Int 112:568–577CrossRefPubMed Kuru TH, Wadhwa K, Chang RT et al (2013) Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. BJU Int 112:568–577CrossRefPubMed
83.
Zurück zum Zitat Borghesi M, Ahmed H, Nam R et al (2017) Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 71:353–365CrossRefPubMed Borghesi M, Ahmed H, Nam R et al (2017) Complications after systematic, random, and image-guided prostate biopsy. Eur Urol 71:353–365CrossRefPubMed
84.
Zurück zum Zitat Wadhwa K, Carmona-Echeveria L, Kuru T et al (2017) Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures. Asian J Androl 19:62–66PubMed Wadhwa K, Carmona-Echeveria L, Kuru T et al (2017) Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures. Asian J Androl 19:62–66PubMed
85.
Zurück zum Zitat Cerruto MA, Vianello F, D’Elia C, Artibani W, Novella G (2014) Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: a comparative evaluation at the same Institution. Archivio Italiano di Urologia e Andrologia 86:284CrossRefPubMed Cerruto MA, Vianello F, D’Elia C, Artibani W, Novella G (2014) Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: a comparative evaluation at the same Institution. Archivio Italiano di Urologia e Andrologia 86:284CrossRefPubMed
86.
Zurück zum Zitat Novella G, Ficarra V, Galfano A et al (2003) Pain assessment after original transperineal prostate biopsy using a coaxial needle. Urology 62:689–692CrossRefPubMed Novella G, Ficarra V, Galfano A et al (2003) Pain assessment after original transperineal prostate biopsy using a coaxial needle. Urology 62:689–692CrossRefPubMed
87.
Zurück zum Zitat Iremashvili VV, Chepurov AK, Kobaladze KM, Gamidov SI (2010) Periprostatic local anesthesia with pudendal block for transperineal ultrasound-guided prostate biopsy: a randomized trial. Urology 75:1023–1027CrossRefPubMed Iremashvili VV, Chepurov AK, Kobaladze KM, Gamidov SI (2010) Periprostatic local anesthesia with pudendal block for transperineal ultrasound-guided prostate biopsy: a randomized trial. Urology 75:1023–1027CrossRefPubMed
88.
Zurück zum Zitat DiBianco JM, Mullins JK, Allaway M (2016) Ultrasound guided, freehand transperineal prostate biopsy: an alternative to the transrectal approach. Urol Pract 3:134–140CrossRef DiBianco JM, Mullins JK, Allaway M (2016) Ultrasound guided, freehand transperineal prostate biopsy: an alternative to the transrectal approach. Urol Pract 3:134–140CrossRef
89.
Zurück zum Zitat Rosario DJ, Lane JA, Metcalfe C et al (2012) Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ 9(344):d7894CrossRef Rosario DJ, Lane JA, Metcalfe C et al (2012) Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ 9(344):d7894CrossRef
90.
Zurück zum Zitat Giannarini G, Crestani A, Rossanese M, Ficarra V (2017) Multiparametric magnetic resonance imaging targeted biopsy for early detection of prostate cancer: all that glitters is not gold! Eur Urol 71:904–906CrossRefPubMed Giannarini G, Crestani A, Rossanese M, Ficarra V (2017) Multiparametric magnetic resonance imaging targeted biopsy for early detection of prostate cancer: all that glitters is not gold! Eur Urol 71:904–906CrossRefPubMed
91.
Zurück zum Zitat Grummet J, Pepdjonovic L, Huang S, Anderson E, Hadaschik B (2017) Transperineal vs. transrectal biopsy in MRI targeting. Transl Androl Urol 6:368–375CrossRefPubMedPubMedCentral Grummet J, Pepdjonovic L, Huang S, Anderson E, Hadaschik B (2017) Transperineal vs. transrectal biopsy in MRI targeting. Transl Androl Urol 6:368–375CrossRefPubMedPubMedCentral
92.
Zurück zum Zitat Hakozaki Y, Matsushima H, Kumagai J et al (2017) A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer. BMC Urol 12(17):117CrossRef Hakozaki Y, Matsushima H, Kumagai J et al (2017) A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer. BMC Urol 12(17):117CrossRef
93.
Zurück zum Zitat Hansen NL, Barrett T, Kesch C et al (2018) Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naive men with suspicion of prostate cancer. BJU Int 122(1):40–49CrossRefPubMed Hansen NL, Barrett T, Kesch C et al (2018) Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naive men with suspicion of prostate cancer. BJU Int 122(1):40–49CrossRefPubMed
94.
Zurück zum Zitat Pepe P, Garufi A, Priolo G, Pennisi M (2017) Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer 15:e33–e36CrossRefPubMed Pepe P, Garufi A, Priolo G, Pennisi M (2017) Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer 15:e33–e36CrossRefPubMed
Metadaten
Titel
Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
verfasst von
Giancarlo Marra
Guillaume Ploussard
Jurgen Futterer
Massimo Valerio
the EAU-YAU Prostate Cancer Working Party
Publikationsdatum
04.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 2/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-02622-5

Weitere Artikel der Ausgabe 2/2019

World Journal of Urology 2/2019 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.